The alliance will combine the two firms' technologies and know-how to provide doctors with insights into patients' health status.
PSS, which develops tools for the IVD space, will supply to Hitachi its nucleic acid isolation system, fully automated diagnostic instruments, and reagents.
Under the terms of the deal, Siemens will expand its kPCR Molecular System menu to include Fast-track's range of tests covering several medical conditions.
The program aims to assist hundreds of people diagnosed with PKU to obtain simple and affordable access to mutation analysis of the PAH gene.
The firms will work to implement MALDI PharmaPulse high-throughput mass spec instrumentation at AMRI's Integrated Drug Discovery Center.
Under the deal, Novartis will access patients who have used Perthera's Precision Cancer Analysis service, which facilitates molecular profiling of cancers.
Infoshield's encryption technology promises the ability to perform calculations and computations without having to first decrypt sensitive data.
The bioinformatics startup has also invested in six other companies, committing $400 million to its data-sharing collaboration.
Imagene will incorporate LifeNome's bioinformatics platform into consumer-facing genetic testing products to be marketed in China and Hong Kong.
As part of the deal, TGen will also become a subsidiary of City of Hope's parent organization, but will remain a non-profit headquartered in Arizona.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.